Insulin Lawsuit represents a key business development partner, working alongside a prominent law firm to identify and qualify eligible claimants in the ongoing insulin price-fixing settlement. Specializing in initial outreach and eligibility screening, they assess whether organizations—typically with 1,000+ employees and self-funded health plans—are a fit. Once screened, they facilitate discovery calls with CEO, CFO, or legal teams to connect prospects directly with the law firm handling the litigation. Operating on a contingency basis, they ensure clients incur no upfront fees, helping maximize recovery without burdening clients before results.